Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature
Authors:
Open Access
- 1 October 2008
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 93 (10) , 3810-3816
Abstract
Context: The reporting quality of randomized controlled trials (RCTs) is poor in general medicine and several areas of specialization but unknown in endocrinology. Objective: Our aim was to assess the reporting quality of RCTs in general endocrinology. A secondary objective was to identify predictors for better reporting quality. Design and Setting: We systematically reviewed RCTs published in three general endocrinology journals between January 2005 and December 2006. Participants: We included parallel-design RCTs that addressed a question of treatment or prevention. Article selection and data abstraction were conducted by two reviewers independently, and disagreements were resolved by consensus. Main Outcomes: There were two main outcomes: 1) a 15-point overall reporting quality score (OQS) based on the Consolidated Standards for Reporting Trials (CONSORT); and 2) a 3-point key score, based on allocation concealment, blinding, and use of intention-to-treat analysis. Results: Eighty nine RCTs were included. The median OQS was 10 (interquartile range = 2). Allocation concealment, blinding, and analysis by intention to treat were reported in 10, 20, and 16 of the 89 RCTs, respectively. A multivariable regression analysis showed that complete industrial funding [incidence rate ratio (IRR) = 1.014; 95% confidence interval (CI), 1.010–1.018], journal of publication (IRR = 1.068; 95% CI, 1.007–1.132), and sample size (IRR = 1.048; 95% CI, 1.026–1.070) were significantly associated with a slightly better OQS. Conclusions: The quality of RCT reporting in general endocrine literature is suboptimal. We discuss our results, highlight the areas where improvements are needed, and provide some recommendations.Keywords
This publication has 36 references indexed in Scilit:
- An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and RecommendationsAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Quality of Randomized Controlled Trials Reporting in the Primary Treatment of Brain TumorsJournal of Clinical Oncology, 2006
- The quality of randomized trial reporting in leading medical journals since the revised CONSORT statementContemporary Clinical Trials, 2005
- Determining the reporting quality of RCTs in clinical pharmacologyBritish Journal of Clinical Pharmacology, 2004
- The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized TrialsAnnals of Internal Medicine, 2001
- Quality of Full and Final Publications Reporting Acute Stroke TrialsStroke, 1998
- Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?The Lancet, 1998
- Improving the Quality of Reporting of Randomized Controlled TrialsJAMA, 1996
- Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviewsThe Lancet, 1996
- The scandal of poor medical researchBMJ, 1994